rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
11
|
pubmed:dateCreated |
2006-12-13
|
pubmed:abstractText |
Bone loss is a common complication after allogeneic stem cell transplantation. Osteoprotegerin (OPG) plays a critical role in bone remodeling by neutralizing the effect of receptor activator of nuclear factor-kappaB ligand (RANKL) on differentiation and activation of osteoclasts. We investigated OPG and RANKL in serum and marrow plasma in transplanted patients.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0041-1337
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
82
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1449-56
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:17164716-Absorptiometry, Photon,
pubmed-meshheading:17164716-Adolescent,
pubmed-meshheading:17164716-Adult,
pubmed-meshheading:17164716-Bone Density,
pubmed-meshheading:17164716-Bone Marrow,
pubmed-meshheading:17164716-Bone Resorption,
pubmed-meshheading:17164716-Female,
pubmed-meshheading:17164716-Graft vs Host Disease,
pubmed-meshheading:17164716-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:17164716-Humans,
pubmed-meshheading:17164716-Longitudinal Studies,
pubmed-meshheading:17164716-Male,
pubmed-meshheading:17164716-Middle Aged,
pubmed-meshheading:17164716-Osteoblasts,
pubmed-meshheading:17164716-Osteoprotegerin,
pubmed-meshheading:17164716-RANK Ligand,
pubmed-meshheading:17164716-Transplantation, Homologous
|
pubmed:year |
2006
|
pubmed:articleTitle |
Imbalance of the osteoprotegerin/RANKL ratio in bone marrow microenvironment after allogeneic hemopoietic stem cell transplantation.
|
pubmed:affiliation |
Department of Biochemistry and Medical Biotechnology, Hematology Branch, Federico II University of Naples, Naples, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|